CEO SUMMARY: In what may be a first for the clinical lab industry, the American Medical Association and the American Hospital Association joined with 20 other healthcare associations to ask CMS Administrator Seema Verma to address the problems with the CMS proposal involving Medicare Part B fees. Specifically, the associations asked Verma to delay implementing
Tag: american association for clinical chemistry
Despite the continuing cutbacks in reimbursement for lab testing, some professional investors still see opportunity in this market sector. On November 13, Genova Diagnostics, Inc., of Asheville, North Carolina, was acquired by Levine Leichtman Capital Partners and “members of management.” The sellers were Nautic Partners and Ferrer Freeman & Company, LLC. Genova’s CEO is Ted
LAST MONTH, THE LABORATORY INDUSTRY lost one its most dedicated, full-time advocates. With his retirement in January, Joe Boone, Ph.D., ended a 31-year career with the Centers for Disease Control and Prevention (CDC).
Boone started with the CDC in 1977. In 1992, he assumed his present position as Associate Director for Science, Division of Laboratory Systems
CEO SUMMARY: Psychiatrist John J. Cannell, M.D., was in a unique position to see the noticeable upward shift in the Vitamin D results reported on his patients by Quest Diagnostics Incorporated over the past 24 months, along with the recent decline in test result levels in recent weeks. His Vitamin D Council and his newsletter,
Last Monday, UroPath, Inc., an Arlington, Texas, company operating anatomic pathology laboratory condominium complexes in several states, disclosed its sale to HealthTronics, Inc., of Austin, Texas. Sales price was $7.75 million. UroPath’s former owners are urologists who founded the company in 2003. (See TDR, August 9, 2004.) HealthTronics sells and maintains lithotripters, laser products, and
CEO SUMMARY: Its time again for THE DARK REPORT to make its yearly selection of the lab industry’s Movers & Shakers. Individuals chosen for 2000 represent a cross section of laboratory companies. Their successes demonstrate that leadership and vision continue to make a difference, despite the financial challenges of today’s healthcare marketplace.
IT IS ALWAYS A
EACH YEAR IT BECOMES more difficult to make final selections for our annual Movers & Shakers awards. The reason is simple.
Today there are more examples of leadership in the laboratory than when we first started these selections three years ago. This is a good omen. It means that the crucible of the marketplace is forging